Case Details
- Citation: [2026] SGHC 65
- Title: Vanbo Investments Pte Ltd v ph. AG & Anor
- Court: High Court of the Republic of Singapore (General Division)
- Date of Decision: 25 March 2026
- Judgment Reserved: 5 January 2026
- Originating Claim No: OC 290 of 2025
- Summonses: SUM 3235/2025; SUM 3248/2025; SUM 3345/2025
- Judges: Tan Siong Thye SJ
- Plaintiff/Applicant: Vanbo Investments Pte Ltd
- Defendants/Respondents: (1) ph. AG; (2) Pedro Schmidt
- Procedural Posture: Applications to set aside a worldwide Mareva injunction; to stay ancillary disclosure; and to stay the High Court proceedings on forum non conveniens and arbitration grounds
- Legal Areas: Civil Procedure; Mareva injunctions; Stay of proceedings; Conflict of laws / jurisdiction clauses; Arbitration-related stay
- Judgment Length: 51 pages, 13,438 words
- Cases Cited: [2026] SGHC 65 (as provided in metadata)
Summary
In Vanbo Investments Pte Ltd v ph. AG & Anor ([2026] SGHC 65), the High Court considered three interlocking procedural applications arising from a commercial dispute involving a Swiss company and a Singapore investment vehicle. The claimant, Vanbo, had obtained a worldwide Mareva injunction ex parte on 14 May 2025, together with an ancillary disclosure order. The defendants applied to set aside the worldwide Mareva injunction and to stay the ancillary disclosure order pending the outcome of the main stay application. In parallel, the defendants sought a stay of the High Court proceedings on the basis that Singapore was forum non conveniens and that parts of the dispute were subject to an arbitration clause.
The court allowed SUM 3235 and SUM 3248. It set aside the worldwide Mareva injunction in its entirety and stayed OC 290. The ancillary disclosure order (SUM 3345) was ordered to be stayed pending the stay application, but became moot once the worldwide Mareva injunction was set aside. Substantively, the court concluded that the defendants had no real risk of dissipation and that Vanbo had not met the stringent requirements for a Mareva injunction, including the need for full and frank disclosure. On the procedural side, the court found no strong cause to deny a stay, including for claims that were governed by an arbitration clause, while addressing concerns about potential fragmentation of proceedings.
What Were the Facts of This Case?
Vanbo Investments Pte Ltd is a Singapore-incorporated holding company engaged in investment activities. Its sole shareholder and director is Mr Zhang Boxuan. The first defendant, ph. AG, is a Swiss-incorporated company primarily involved in manufacturing, distributing, marketing, and providing consultancy for a product described as a cortisol stress reducer beverage (“KA-EX Product”). The product is made up of two components: a powder produced by DSM Fiermenich AG and a push-cap produced by Vicap Global AG (“ViCap”). The parties’ commercial premise was that the two components were designed to function optimally together.
The second defendant, Mr Pedro Schmidt (“Mr Schmidt”), is the founder of ph. AG and serves as chairperson of its board. The board also included other directors, including Mr Boxuan (Vanbo’s nominee director), and two other individuals, Mr David Guntern and Mr Roger Wilfinger. The dispute arose out of Vanbo’s investment in ph. AG and the subsequent breakdown of the parties’ relationship regarding product licensing, governance, and shareholding maintenance.
From around July to September 2024, Vanbo and ph. AG engaged in discussions about a potential investment and business partnership to expand the KA-EX Product into the Asia-Pacific region. These discussions culminated in a non-binding term sheet executed on 24 September 2024. Under the term sheet, Vanbo would invest approximately CHF 1.5 million to acquire 24,312 newly issued preferred shares and receive exclusive rights to manufacture and distribute the product in specified territories (Asia, Australia, and New Zealand). After further discussions, the parties executed two key agreements: a license agreement (around 27 November 2024) and an investment agreement (on 6 December 2024).
Under the license agreement, Vanbo was granted exclusive rights to use the KA-EX brand and manufacture products in the designated territories, subject to meeting ph. AG’s quality standards. Under the investment agreement, Vanbo’s CHF 1.5 million investment was formalised in exchange for 12.5% of ph. AG’s total ordinary shares and the right to nominate a board representative. The investment agreement also automatically bound Vanbo to the term sheet and a shareholders’ agreement, although Vanbo disputed that automatic binding. Vanbo completed due diligence, signed a subscription form on 21 December 2024, and transferred the consideration on 7 January 2025, after which it was allocated the shares.
What Were the Key Legal Issues?
The first key issue was whether the worldwide Mareva injunction should be set aside. Mareva relief is an exceptional form of interim restraint designed to prevent a defendant from dissipating assets to frustrate a claimant’s ability to enforce a judgment. The court had to assess whether there was a real risk of dissipation and whether the claimant had satisfied the high threshold for obtaining such relief, including the requirement of full and frank disclosure at the ex parte stage. The defendants also challenged the merits, arguing that Vanbo had no good arguable case.
The second issue concerned the ancillary disclosure order. The disclosure order had been granted together with the worldwide Mareva injunction. If the Mareva injunction fell away, the disclosure order’s continued justification would be undermined. The court therefore had to decide whether disclosure should remain pending the final determination of the Mareva set-aside application, and ultimately whether it should be treated as moot once the Mareva injunction was set aside.
The third issue was whether the High Court proceedings should be stayed. The defendants invoked two grounds: (1) forum non conveniens, arguing that Singapore was not the appropriate forum; and (2) the existence of an arbitration clause covering parts of the dispute. The court had to interpret the jurisdiction clause and determine whether there was “strong cause” to refuse a stay, taking into account factors such as the parties’ connections to Singapore, the availability of witnesses and evidence, the governing law of the claims, and whether any stay would prejudice Vanbo or involve abusive conduct by the defendants. The court also had to manage the practical concern of potential fragmentation of proceedings if some claims proceeded in arbitration while others remained in court.
How Did the Court Analyse the Issues?
The court’s analysis of SUM 3235 (setting aside the worldwide Mareva injunction) proceeded through the core Mareva requirements. Although the judgment extract provided is truncated, the structure of the reasoning is clear: the court addressed whether there was a real risk of dissipation, the nature of the defendants’ assets, the alleged refusal to comply with an ancillary disclosure order, the defendants’ financial standing, and allegations of dishonesty and lack of transparency. These factors are typical of Mareva assessments because they go to the likelihood that the defendant will move assets beyond the reach of the court, thereby defeating the claimant’s eventual judgment.
On the “real risk of dissipation” limb, the court concluded that there was no real risk. The reasoning, as reflected in the judgment’s headings, suggests that the court scrutinised the defendants’ asset profile and financial position, and considered whether there was evidence that the defendants were likely to frustrate enforcement. The court also considered Vanbo’s allegations that the defendants had acted dishonestly and lacked transparency. However, the court was not persuaded that these allegations, even if asserted, established the necessary evidential foundation for Mareva relief.
In addition, the court addressed whether Vanbo had a good arguable case on the merits. Mareva injunctions are not meant to be a substitute for trial; however, the claimant must still show that its claim is not frivolous or vexatious and that there is a serious question to be tried. The court found that there was no good arguable case on the merits. This conclusion is particularly significant because it indicates that the court did not treat the dispute as one where the claimant’s allegations were sufficiently credible to justify freezing assets globally.
Crucially, the court also found that Vanbo had not made full and frank disclosure. This is a central principle in ex parte applications for Mareva injunctions. The duty of candour requires the claimant to present the court with all material facts, including those that may undermine the application. Where that duty is breached, the court may set aside the injunction even if the claimant’s case might otherwise appear arguable. The court’s finding that Vanbo did not provide full and frank disclosure reinforces the strictness of Mareva practice in Singapore and signals that procedural fairness and candour are not merely formalities but substantive requirements.
Turning to SUM 3248 (the stay application), the court analysed the jurisdiction clause and the forum non conveniens/arbitration framework. The court considered the governing law of the claims and the extent to which the dispute was contractually channelled into arbitration. The headings indicate that the court distinguished between contractual and restitutionary claims on the one hand, and tortious claims on the other, because different governing law rules may apply depending on the legal characterisation of each cause of action. This matters because the governing law can influence where the dispute should be heard and which forum is best placed to determine the issues.
The court then assessed whether there was “no strong cause to deny a stay” of OC 290. It considered personal connections of the parties, the availability of witnesses and evidence, and whether the governing law pointed towards Singapore or away from it. The court also considered whether Vanbo would be prejudiced by a stay and whether the defendants had engaged in abusive conduct. The court’s conclusion that there was no strong cause to deny a stay suggests that the balance of convenience and procedural efficiency favoured a stay, particularly given the arbitration clause for at least part of the dispute.
Finally, the court addressed the potential fragmentation of proceedings. Fragmentation is often raised as a practical objection to staying court proceedings in favour of arbitration, because it can lead to parallel processes and inconsistent findings. The court, however, appears to have accepted that fragmentation was manageable and did not outweigh the contractual and procedural reasons to stay. This is consistent with Singapore’s pro-arbitration approach, where courts generally respect arbitration agreements and will stay litigation to give effect to party autonomy, unless there are compelling reasons not to.
What Was the Outcome?
The High Court allowed SUM 3235 and set aside the worldwide Mareva injunction granted ex parte on 14 May 2025. The court also allowed SUM 3248 and stayed OC 290. As a result, the claimant’s ability to rely on the worldwide freezing order was removed, and the substantive dispute was directed away from the High Court process pending the outcome of the stay framework (including arbitration where applicable).
During the hearing, the court ordered the stay of the disclosure provision of the worldwide Mareva injunction (SUM 3345) pending the outcome of the stay application. Once the worldwide Mareva injunction was set aside entirely, SUM 3345 became moot. Practically, this means that the ancillary disclosure obligations tied to the Mareva order could not survive independently once the foundational freezing relief was withdrawn.
Why Does This Case Matter?
This decision is important for practitioners because it illustrates the strict approach Singapore courts take to Mareva injunctions, particularly where relief is sought ex parte. The court’s findings on (i) absence of a real risk of dissipation, (ii) lack of a good arguable case on the merits, and (iii) failure to make full and frank disclosure collectively demonstrate that Mareva relief will not be sustained where the evidential and procedural requirements are not met. For claimants, the case underscores that the duty of candour is decisive: even where a claimant believes it has a strong narrative, the court will scrutinise whether the application was presented with complete and accurate material facts.
From a litigation strategy perspective, the case also highlights how quickly interim relief can be dismantled once the court is satisfied that the claimant’s procedural obligations were not fulfilled. Defendants seeking to set aside Mareva orders should focus not only on the substantive risk of dissipation but also on the integrity of the ex parte application, including omissions or misleading emphasis.
More broadly, the stay analysis reinforces Singapore’s arbitration-friendly stance. Where an arbitration clause covers parts of the dispute, and where the forum non conveniens factors do not strongly favour Singapore, courts will generally stay High Court proceedings to respect the contractual allocation of disputes. The court’s willingness to stay even in the face of potential fragmentation signals that efficiency and party autonomy will often prevail over concerns about parallel proceedings, provided that prejudice to the claimant is not compelling.
Legislation Referenced
- (Not provided in the supplied judgment extract and metadata.)
Cases Cited
- [2026] SGHC 65 (as provided in metadata)
Source Documents
This article analyses [2026] SGHC 65 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.